DUKE UNIVERSITY - PHARMACOKINETIC AND SAFETY OF ANTIRETROVIRAL AND RELATED DRUGS LACTATING WOMEN AND BREASTFED INFANTS STUDY

On Jan 28, 2026, Department of Health and Human Services obligated $685,624 to DUKE UNIVERSITY for pharmacokinetic and safety of antiretroviral and related drugs lactating women and breastfed infants study. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost no fee contract. Competition extent: full and open competition. Performance is located in DURHAM, NC. The contract is scheduled through Jun 30, 2026 — approximately 1 month remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.